NPS RADAR provides health professionals with timely, independent evidence-based information on new drugs and medical tests and changes to listings on the Pharmaceutical Benefits Scheme.

NPS RADAR is print-published 3 times a year, in line with major updates to the Schedule of Pharmaceutical Benefits, so it is available around the time when new medicines can be prescribed or dispensed.

Our free NPS RADAR email alerts keep subscribers up to date with new drugs and medical tests as each new issue of NPS RADAR is released.

Latest issue

Ivermectin (Stromectol) for typical and crusted scabies

Ivermectin (Stromectol) was recently given TGA approval and is now PBS listed for the treatment of typical and crusted scabies. Where does ivermectin fit in treatment?

Ferric carboxymaltose (Ferinject) for iron-deficiency anaemia

Ferric carboxymaltose (Ferinject) is a PBS-listed parenteral iron preparation with characteristics that allow larger single doses to be administered over a shorter infusion period compared with existing IV iron preparations.

Tapentadol sustained release (Palexia SR) for chronic, severe disabling pain

Tapentadol SR is a centrally acting opioid analgesic used for treating chronic, severe disabling pain not responding to non-opioid analgesics.